Abstract

It is difficult to cross-validate the parameters measured by different modalities. Our in vivo small animal study is the first to validate a true multi-modality system (combined MRI-DOT system) with a true multi-modality contrast agent.

© 2011 Optical Society of America

PDF Article
More Like This
In-vivo optical contrast agent dynamics in tumors with MRI co-registration

David J. Cuccia, Fred Bevilacqua, Anthony J. Durkin, Bruce J. Tromberg, Gultekin Gulsen, Hon Yu, Jun Wang, and Orhan Nalcioglu
TuG2 Frontiers in Optics (FiO) 2003

Multimodality Approach for Functional and Molecular Imaging of Cancer

Gultekin Gulsen
BMB2 Bio-Optics: Design and Application (BODA) 2011

Pharmacokinetic Analysis for Tumor Characterization Using MR-Guided Dynamic Contrast Enhanced Diffuse Optical Tomography

Mitchell Hsing, Yuting Lin, and Gultekin Gulsen
BTu2A.3 Biomedical Optics (BIOMED) 2012

References

You do not have subscription access to this journal. Citation lists with outbound citation links are available to subscribers only. You may subscribe either as an OSA member, or as an authorized user of your institution.

Contact your librarian or system administrator
or
Login to access OSA Member Subscription